18-31544461-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001943.5(DSG2):c.2335-1260C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.257 in 151,824 control chromosomes in the GnomAD database, including 5,316 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.26 ( 5316 hom., cov: 32)
Consequence
DSG2
NM_001943.5 intron
NM_001943.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.355
Publications
2 publications found
Genes affected
DSG2 (HGNC:3049): (desmoglein 2) This gene encodes a member of the desmoglein family and cadherin cell adhesion molecule superfamily of proteins. Desmogleins are calcium-binding transmembrane glycoprotein components of desmosomes, cell-cell junctions between epithelial, myocardial, and other cell types. The encoded preproprotein is proteolytically processed to generate the mature glycoprotein. This gene is present in a gene cluster with other desmoglein gene family members on chromosome 18. Mutations in this gene have been associated with arrhythmogenic right ventricular dysplasia, familial, 10. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.488 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DSG2 | NM_001943.5 | c.2335-1260C>T | intron_variant | Intron 14 of 14 | ENST00000261590.13 | NP_001934.2 | ||
| DSG2-AS1 | NR_045216.1 | n.1517-1066G>A | intron_variant | Intron 4 of 5 | ||||
| DSG2 | XM_047437315.1 | c.1801-1260C>T | intron_variant | Intron 15 of 15 | XP_047293271.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.257 AC: 39002AN: 151706Hom.: 5308 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
39002
AN:
151706
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.257 AC: 39025AN: 151824Hom.: 5316 Cov.: 32 AF XY: 0.263 AC XY: 19518AN XY: 74206 show subpopulations
GnomAD4 genome
AF:
AC:
39025
AN:
151824
Hom.:
Cov.:
32
AF XY:
AC XY:
19518
AN XY:
74206
show subpopulations
African (AFR)
AF:
AC:
8168
AN:
41380
American (AMR)
AF:
AC:
4030
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
AC:
614
AN:
3466
East Asian (EAS)
AF:
AC:
2604
AN:
5162
South Asian (SAS)
AF:
AC:
1206
AN:
4802
European-Finnish (FIN)
AF:
AC:
3645
AN:
10504
Middle Eastern (MID)
AF:
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18031
AN:
67962
Other (OTH)
AF:
AC:
518
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1484
2968
4451
5935
7419
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
406
812
1218
1624
2030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1284
AN:
3472
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.